Certified by Founder Lodge
Umoja Biopharma
United States - Seattle, Washington
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patie
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 21 ,2025 | Series C | $100,000,000 |
Alexandria Real Estate Equities, Inc.
Qiming Venture Partners USA
RTW Investments, LP
DCVC Bio
K2 HealthVentures
MPM BioImpact
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)